Ilkka Oyj (LON:0IGX)
3.950
+0.130 (3.40%)
At close: Jan 5, 2026
Ilkka Oyj Revenue
Ilkka Oyj had revenue of 9.01M EUR in the quarter ending September 30, 2025, with 33.71% growth. This brings the company's revenue in the last twelve months to 59.64M, up 63.19% year-over-year. In the year 2024, Ilkka Oyj had annual revenue of 53.93M, down -3.86%.
Revenue (ttm)
59.64M EUR
Revenue Growth
+63.19%
P/S Ratio
1.70
Revenue / Employee
123.48K EUR
Employees
483
Market Cap
88.72M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 53.93M | -2.16M | -3.86% |
| Dec 31, 2023 | 56.09M | 1.71M | 3.13% |
| Dec 31, 2022 | 54.39M | 4.73M | 9.53% |
| Dec 31, 2021 | 49.65M | 3.85M | 8.40% |
| Dec 31, 2020 | 45.81M | 9.38M | 25.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |